220 related articles for article (PubMed ID: 38590581)
1. Microbiota analysis in individuals with type two diabetes mellitus and end‑stage renal disease: A pilot study.
Trandafir M; Pircalabioru GG; Savu O
Exp Ther Med; 2024 May; 27(5):211. PubMed ID: 38590581
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
3. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
4. Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease.
Salguero MV; Al-Obaide MAI; Singh R; Siepmann T; Vasylyeva TL
Exp Ther Med; 2019 Nov; 18(5):3461-3469. PubMed ID: 31602221
[TBL] [Abstract][Full Text] [Related]
5. Uremic Toxin-Producing
Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
[TBL] [Abstract][Full Text] [Related]
6. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease.
Zhang P; Wang X; Li S; Cao X; Zou J; Fang Y; Shi Y; Xiang F; Shen B; Li Y; Fang B; Zhang Y; Guo R; Lv Q; Zhang L; Lu Y; Wang Y; Yu J; Xie Y; Wang R; Chen X; Yu J; Zhang Z; He J; Zhan J; Lv W; Nie Y; Cai J; Xu X; Hu J; Zhang Q; Gao T; Jiang X; Tan X; Xue N; Wang Y; Ren Y; Wang L; Zhang H; Ning Y; Chen J; Zhang L; Jin S; Ren F; Ehrlich SD; Zhao L; Ding X
Genome Biol; 2023 Oct; 24(1):226. PubMed ID: 37828586
[TBL] [Abstract][Full Text] [Related]
7. Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.
Li J; Xing H; Lin W; Yu H; Yang B; Jiang C; Zhang J; Wu R; Ding F; Pei M; Yang H
Front Med (Lausanne); 2023; 10():1302352. PubMed ID: 38249961
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.
Luo D; Zhao W; Lin Z; Wu J; Lin H; Li Y; Song J; Zhang J; Peng H
Front Cell Infect Microbiol; 2021; 11():579386. PubMed ID: 33834002
[TBL] [Abstract][Full Text] [Related]
9. Gut dysbiosis-influence on amygdala-based functional activity in patients with end stage renal disease: a preliminary study.
Zheng LJ; Lin L; Zhong J; Zhang Z; Ye YB; Zhang XY; Wang YF; Zhang H; Liu Y; Lu GM; Gong D; Zhang LJ
Brain Imaging Behav; 2020 Dec; 14(6):2731-2744. PubMed ID: 32304020
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
[TBL] [Abstract][Full Text] [Related]
11. Gut-Derived Protein-Bound Uremic Toxins.
Graboski AL; Redinbo MR
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal Autonomic Neuropathy Exacerbates Gut Microbiota Dysbiosis in Adult Patients With Type 2 Diabetes Mellitus.
Du Y; Neng Q; Li Y; Kang Y; Guo L; Huang X; Chen M; Yang F; Hong J; Zhou S; Zhao J; Yu F; Su H; Kong X
Front Cell Infect Microbiol; 2021; 11():804733. PubMed ID: 35211420
[TBL] [Abstract][Full Text] [Related]
13. Increased chronic kidney disease development and progression in diabetic patients after appendectomy: a population-based cohort study.
Chang CH; Kor CT; Wu CL; Chiu PF; Li JR; Tsai CC; Chang TH; Chang CC
PeerJ; 2018; 6():e5019. PubMed ID: 29915707
[TBL] [Abstract][Full Text] [Related]
14. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
15. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents.
Wang X; Yang S; Li S; Zhao L; Hao Y; Qin J; Zhang L; Zhang C; Bian W; Zuo L; Gao X; Zhu B; Lei XG; Gu Z; Cui W; Xu X; Li Z; Zhu B; Li Y; Chen S; Guo H; Zhang H; Sun J; Zhang M; Hui Y; Zhang X; Liu X; Sun B; Wang L; Qiu Q; Zhang Y; Li X; Liu W; Xue R; Wu H; Shao D; Li J; Zhou Y; Li S; Yang R; Pedersen OB; Yu Z; Ehrlich SD; Ren F
Gut; 2020 Dec; 69(12):2131-2142. PubMed ID: 32241904
[TBL] [Abstract][Full Text] [Related]
16. Homeostasis in the Gut Microbiota in Chronic Kidney Disease.
Bhargava S; Merckelbach E; Noels H; Vohra A; Jankowski J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287917
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
Taguchi K; Fukami K; Elias BC; Brooks CR
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
[TBL] [Abstract][Full Text] [Related]
18. Huang Gan Formula Alleviates Systemic Inflammation and Uremia in Adenine-Induced Chronic Kidney Disease Rats May Associate with Modification of Gut Microbiota and Colonic Microenvironment.
Zhao J; Zhao C; Xun T; Wang X; Wei S; Ye C; Zhang M; Guo D; Yang X
Drug Des Devel Ther; 2024; 18():13-28. PubMed ID: 38205394
[TBL] [Abstract][Full Text] [Related]
19. Microbiota issue in CKD: how promising are gut-targeted approaches?
Cosola C; Rocchetti MT; Sabatino A; Fiaccadori E; Di Iorio BR; Gesualdo L
J Nephrol; 2019 Feb; 32(1):27-37. PubMed ID: 30069677
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]